You have 9 free searches left this month | for more free features.

Bendamustine Hydrochloride

Showing 1 - 25 of 1,816

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
Oct 21, 2021

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Not yet recruiting
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Mar 9, 2022

Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Sacramento (Bendamustine Hydrochloride, Brentuximab

Recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Bendamustine Hydrochloride
  • Brentuximab Vedotin
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 17, 2021

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Classical Hodgkin Lymphoma Trial in Atlanta (Bendamustine, Gemcitabine,

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +1 more
Aug 25, 2021

Non-Hodgkin's Lymphoma Trial in Japan (bendamustine HCl)

Completed
  • Non-Hodgkin's Lymphoma
  • bendamustine hydrochloride
  • Kanagawa, Japan
  • +3 more
Oct 19, 2020

Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma, Non Hodgkin Lymphoma Trial in Winston-Salem (CPI 613, Bendamustine)

Recruiting
  • Relapsed T-Cell Lymphoma
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Aug 27, 2021

Indolent Non-hodgkin Lymphoma Trial in München (Obinutuzumab, Bendamustine)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • München, Bavaria, Germany
    Klinikum der Universität München
Jul 23, 2021

Advanced Solid Tumor Trial in Chuo-ku, Tokyo, Osakasayama (SyB C-0501)

Completed
  • Advanced Solid Tumor
  • SyB C-0501
  • Chuo-ku, Tokyo, Japan
  • +1 more
Apr 25, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 7, 2021

Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Apr 4, 2022

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
Apr 21, 2021

Diffuse Large B Cell Lymphoma Trial in Saint-Petersburg (Bendamustine HCl, Gemcitabine 500 mg, Gemcitabine 700 mg)

Completed
  • Diffuse Large B Cell Lymphoma
  • Bendamustine hydrochloride
  • +5 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Jun 2, 2021

Lymphoma, Mantle-Cell Trial in Czechia (Polatuzumab vedotin, Bendamustine Hydrochloride, Rituximab)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Polatuzumab vedotin
  • +2 more
  • Brno, Czechia
  • +6 more
May 28, 2021

Indolent B-Cell Non-Hodgkin's Lymphomas Trial in China (Bendamustine HCl injection)

Completed
  • Indolent B-Cell Non-Hodgkin's Lymphomas
  • Bendamustine hydrochloride injection
  • Fuzhou, Fujian, China
  • +10 more
Sep 25, 2020

Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Jun 21, 2021

Refractory Multiple Myeloma Trial in United States (bendamustine HCl, lenalidomide, dexamethasone)

Completed
  • Refractory Multiple Myeloma
  • bendamustine hydrochloride
  • +2 more
  • Duarte, California
  • +4 more
Feb 10, 2020

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Symbenda Post-Marketing Surveillance (PMS)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
    • Busan, Korea, Republic of
    • +8 more
    Jan 25, 2021

    Hodgkin's Lymphoma Trial in Saint-Petersburg (Nivolumab, Bendamustine Hydrochloride)

    Completed
    • Hodgkin's Lymphoma
    • Saint-Petersburg, Russian Federation
      First Pavlov State Medical University of St. Petersburg
    May 27, 2020

    Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is

    Completed
    • Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
    • Test Product (Bendamustine)
    • Long Beach, California
    • +9 more
    Jun 2, 2021

    Non-Hodgkin's Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Japan (SyB L-0501, Rituximab)

    Completed
    • Non-Hodgkin's Lymphoma
    • +3 more
    • Nagoya-city, Aichi, Japan
    • +3 more
    Jul 1, 2021

    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Philadelphia (Bendamustine HCl,

    Completed
    • Stage I Multiple Myeloma
    • +2 more
    • Bendamustine hydrochloride
    • +2 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Aug 27, 2019

    Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide, Fludarabine, Rituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 14, 2020